NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Estimated value
—
Awarded value
£22.1m
Suppliers
8
Lots
1
Published
11 Jul 2025
Description
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework. Additional Unsuccessful supplier not listed due to technical error: Torrent Pharma (UK) Ltd
Scope
- Reference
- C352808
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2025 to 31 Jan 2027Possible extension to 31 Jan 2029
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Price is not the only award criterion | Price is not the only award criterion and all criteria are stated only in the procurement documents | price | 100.00% |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£22.1m
Award date
11 Jun 2025
Contract start
31 Aug 2025
Contract end
31 Jan 2027